V. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS PRELIMINARY PROGRAM

- How Should We Treat Hodgking Lymphoma?

Hodgkin's Lymphoma : Diagnosis and Staging

First-line Therapy ,Evaluation of Response and Second line Therapy

- How Should We Treat MDS?

Myelodysplastic Syndromes : Old and New Classifications and Prognostic Scores

Therapy of MDS

New Drugs in MDS

Essential Therapeutic Approach to the MDS Patient

Special Lecture: Iron Overload and MDS

- The Future : New Targets for the Therapy of Hematological Malignancies

New Targets in ALL

New Targets in AML : Only for Minimal Residual Disease?

New Targets in MPNs

New Indications for Old Antibodies : HUS . PNH Disease Model

- Infections in Hematology

IFI Management : Putting Theory into Pratice

New Antibiotic Strategy in Neutropenia

Profilactic Anti Fungal Treatment in Hematologic Malignancies

- How to manage Myeloid and Lymphoid Chronic Leukemias and MPNs

Chronic Lymphocytic Leukemia : Essential Steps for a Correct Risk Stratification

CLL : Old and New Therapies

CML : How Do We Have to Treat our CML Patients in the era of Genetic Imatinib?

Steps Towards Treatment Discontinuation : Why , in Which Patients , When and How

MPNs : What's Really New in the Classification , Prognosis and Therapy?

How I Manage PV

- How to manage Acute Leukemias

The Essential Management of AML

The Essential Management of Adult ALL

Present and Future of Ph-Positive ALL Treatment

Which Acute Leukemia Patients and When to be Referred to Transplant Centers?

- How to treat Multiple Myeloma

Multiple Myeloma : Which is the Best and Most Convenient during the First-line Therapy?

Management of Relapses and Refractory Cases

Optimizing Treatment of MM Complications

New Drugs in MM

- Stem Cell Transplant

What is Essential to Know About Stem Cells

The Autologous Transplant : Essential Indication

Advances in Mobilization Failure

Haploidentical Stem Cell Transplant

Cord Blood Transplant : a Reliable Alternative for Elderly Patients?

- Non Hodgkin Lymphoma

How I Manage Indolent Non-HL

How I Manage Mantle Cell Lymphoma

How I Manage DLBCLs Cell Lymphoma

How I manage peripheric T-cell Lymphomas

Is MRD Detection Really Needed for Lymphoproliferative Treatment?